Documents Explode Tibetan Troops’ Vaccine Shortage to Hebei – Hebei Province belongs to the first echelon of the Communist Party’s vaccine distribution Documents leak Hebei’s internal priority to protect “Beidaihe Summer”

Currently, China is relatively slower than Western countries when it comes to vaccination, and one of the main reasons for this is that many people on the mainland question the safety and efficacy of domestically produced vaccines. Pictured is a diagram of the COVID-19 vaccine.

The Chinese Communist Party is currently implementing a phased vaccination program on the mainland. Recently, internal documents obtained by the Epoch Times revealed that Hebei prioritized the distribution of vaccines to protect major “political tasks” such as the “Beidaihe summer”. At the same time, the Tibetan border troops are short of vaccines and have internally requested Hebei to support them.

Exclusive: Tibetan border troops lack vaccines and ask for help from Hebei

The report of “Report on the Tibetan Ali region’s plea to our province for assistance in solving part of the new crown pneumonia (CCP pneumonia) vaccine” was obtained from the CPC’s Hebei Provincial Aid to Tibet Forward Work Coordination Group on April 1. The report leaked that there is a lack of vaccine in Tibetan area. Tibetan Party Secretary Wu Yingjie, at the meeting, “actively approached and implored the counterpart provinces and cities to provide assistance in the vaccine shortage.”

The document said that the Ali region borders two countries with serious epidemics, India and Nepal, and with a large number of troops assembled and mobile population at the border, the pressure of epidemic prevention and control is greater. The main leaders of the Ali local party committee, according to the work deployment requirements of the Tibet Autonomous Region Party Committee, “requested the provincial task force of Hebei and Shaanxi to grant Tibet to report to the provincial government of this province to allocate assistance to solve the vaccine gap difficulties, including a request to Hebei Province to assist the new crown (Chinese Communist virus) vaccine for 10,000 people (20,000 doses).”

(Epoch Times)

Exclusive: Hebei Vaccine Allocation Prioritized for “Beidaihe Summer”

The Epoch Times obtained the “Notice on the Phased Vaccination of New Coronavirus (CCP) Vaccines for Various Populations in the Province” issued by the Hebei Province Leading Group for the Response to the Epidemic on March 13 of this year. The document was noted as “special mention” (a top-level telegram that needs to be processed immediately) and “not to be disclosed.

On March 15, Baoding City’s Leading Group for Response to the Epidemic forwarded the above notice in the form of a document.

The document revealed that the CCP’s phased vaccination program was a “political task. According to the document, the leading group of cities to deal with the epidemic should raise their “political status” and take the vaccination work as the “number one task” of the current epidemic prevention and control work, and arrange the vaccination plan precisely.

The document says that the first step of the first stage of vaccination of key populations should be completed before March 15.

The first step is to vaccinate the second stage target group. This includes people over 18 years of age in key port areas and elderly people who need to be vaccinated for special reasons and are in good physical condition, which need to be completed by the end of June.

The document specifically mentions that after completing the vaccination of the above-mentioned people, the scope of the target population for vaccination will be further expanded. The main reason for this is that the province has major tasks such as “guarding the security of the capital, the Winter Olympics, the summer security of Beidaihe, and the construction of Xiongan New Area”. The province must basically cover 50% of its population by the end of June.

The second step of Hebei’s vaccination program begins in July.

According to reports, July and August is the time of year when the Communist Party’s top brass meets in Beidaihe. Officials do not disclose when the meetings are held and when they end, so outsiders can only judge from official actions in Hebei and the tense security situation there.

Current affairs commentator Li Linyi said that the distribution of vaccines within the CCP is also political first. Ironically, the troops guarding the border in Tibet are not getting vaccines and have come to ask Hebei for them. Instead, the Hebei authorities have a bunch of political projects, hoping to inoculate the area around Beidaihe, including Qinhuangdao, by July, in order to guarantee the personal safety of top Communist Party officials who come on vacation.

According to Li Linyi, this shows that the CCP does not really take the personal safety of front-line soldiers and people seriously, but considers more the lives and safety of the top brass.

Exclusive: CCP gives priority to supplying vaccines to Beijing, Hebei belongs to the first tier

In addition, the Communist Party of China (CPC) gave priority to supplying vaccines to Beijing, as revealed in the “Circular on the Vaccination of the New Coronavirus (CPC virus) (II),” which was “withheld” by the CPC State Council’s Joint Prevention and Control Mechanism Vaccination Coordination Group on April 1.

The document revealed that 14 provinces including Beijing, Tianjin, Hebei, Heilongjiang, Shanghai and Xinjiang Production and Construction Corps were included in the first echelon of vaccination in accordance with the principle of “highlighting the key points and advancing in a gradual manner”, requiring the completion of the first dose of vaccination by the end of April, while other provinces were included in the subsequent echelon.

From the “Table of Vaccination and Supply of New Coronavirus (CCLV) Vaccines in Different Places” attached to the document (as of March 28), Beijing is the focus of vaccination with a cumulative supply of 150.772 (million doses) and a cumulative number of 14.223 (million doses), followed by Guangdong (cumulative supply of 8.499 million doses) and Shandong (cumulative supply of 7.053 million doses).

Behind the violation of international practices in vaccination principles on the mainland

Currently, China is relatively slower than Western countries when it comes to vaccination, and one of the main reasons for this is that many mainlanders question the safety and efficacy of domestically produced vaccines.

In addition, while older people in Western countries are given priority in vaccination, China’s previous vaccination program was limited to those aged 18 to 59, and was only recently opened to the 60+ age group.

Gao Fu, director of the Communist Party’s Center for Disease Control and Prevention, sparked controversy in early March over whether older people should be vaccinated first. In an interview with the mainland media, he said, “Whether to vaccinate, when to vaccinate, and how to vaccinate has always been a question of balancing risk and benefit.”

Dr. Wang, a retired Hebei doctor, told Voice of America that authorities also put down the word that people over 60 are not to be vaccinated now because the vaccine may be limited, and also that older people are past retirement age and have a relatively narrow range of activities and fewer social activities, plus more people over 60 suffer from chronic diseases, so the vaccine is mainly focused on people under 60.

Hu Ping, a political commentator based in New York, said that the elderly especially need protection, but the Chinese Communist Party is doing the opposite, probably because it is not sure about the vaccine and does not dare to administer it to the elderly. When more experimental data is available, it will determine whether to give the vaccine to the elderly.

Reuters reports that in many countries, especially those receiving the Chinese vaccine, the elderly are usually first or second in the vaccination queue and given priority.

As of press time, the Chinese-made vaccine, in addition to failing to fully provide data from phase III clinical trials, has not been approved by the World Health Organization.